Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis
Related Experiment Videos
1Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285, USA.
Insights
Oxidized low-density lipoprotein (LDL) causes vascular dysfunction in hypercholesterolemia and atherosclerosis. Lipid-lowering therapy and antioxidants improve vascular function, supporting oxidized LDL's role in coronary artery disease.
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
- Vascular Biology
Background:
- Hypercholesterolemia and atherosclerosis are linked to significant vascular dysfunction.
- Oxidized low-density lipoprotein (LDL) is implicated in these vascular pathologies.
Purpose of the Study:
- To investigate the role of oxidized LDL in vascular dysfunction.
- To explore the therapeutic potential of interventions targeting oxidized LDL.
Main Methods:
- Analysis of vasomotor responses in isolated blood vessels.
- Evaluation of lipid-lowering therapy and antioxidant effects.
Main Results:
- Oxidized LDL significantly impacts blood vessel vasomotor responses.
- Lipid-lowering therapies and antioxidants demonstrate beneficial effects on vascular function.
- Evidence supports oxidized LDL's causative role in in vivo vascular dysfunction.
Conclusions:
- Oxidized LDL is a key mediator of vascular dysfunction in conditions like hypercholesterolemia and atherosclerosis.
- Targeting oxidized LDL may offer novel therapeutic strategies for coronary artery disease management.
Abstract:
Oxidized LDL exerts profound effects on the vasomotor response of isolated blood vessels to various stimuli that closely mimic the vascular dysfunction associated with hypercholesterolemia and atherosclerosis in humans. The beneficial effect of lipid-lowering therapy in normalizing vascular function and greatly decreasing the frequency of clinical events associated with atherosclerosis, combined with the ability of antioxidants to alleviate vasomotor disturbances in hypercholesterolemia and slow the progression of atherosclerosis, strongly support a causative role of oxidized LDL in mediating vascular dysfunction in vivo and contributing to the clinical sequalae of coronary artery disease. Further research to understand more fully the mechanisms of oxidized LDL formation and actions in vivo may reveal novel strategies to inhibit these events, and may prove beneficial in the therapeutic management of atherosclerotic disease.